In the COVID-19 pandemic, thrombocytopenia occurring in vaccine-associated thrombosis has been called “COVID-19 vaccine-associated (immune) thrombosis and thrombocytopenia (VITT)” [1,23,24], often related to platelet factor 4 (PF4) antibodies [25,26]. This evidence concerns the gene PF4 and deep vein thrombosis.